We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Natural Killer T-Cells Trigger Asthma

By Biotechdaily staff writers
Posted on 18 Apr 2003
Researchers working with a mouse model for human asthma have found that asthma developed only when the animals had natural killer T-cells (NKT cells) in their lungs.

In a study published March 31, 2003, in the online edition of Nature Medicine, investigators at the Stanford University Medical Center (Stanford, CA, USA) described a series of experiments performed with a line of mice genetically engineered to lack NKT cells.

They found that exposing these mice to airborne antigens known to stimulate asthma failed to induce airway hyper-reactivity (AHR) despite the presence of type 2 T-helper (Th2) cells, which normally trigger mucous production and airway constriction. More...
When the mice lacking NKT were injected with NKT cells, they responded to the airborne antigens by developing asthma similarly to control animals.

"We were quite surprised by the clarity with which the mice either got asthma or not depending on whether or not they had NKT cells,” said senior author Dr. Dale Umetsu, professor of pediatrics at the Stanford University School of Medicine. "Prior to these studies, one assumed that Th2 cells were all that was needed to induce asthma, and they do play a very important role in asthma pathogenesis. Now it is clear that even if you have Th2 cells but you do not have NKT cells, you do not get asthma.”

The essential role of the NKT cells makes them logical targets for asthma therapy. "We are starting to look at people to see how these NKT cells may affect the development of asthma,” said Dr. Umetsu. " If we can find specific surface markers, we may be able to direct therapies specifically against the NKT cells to eliminate them.”



Related Links:
Stanford University Medical Center

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.